Ribuvaptan

Ribuvaptan is a vasopressin receptor antagonist. Ribuvaptan can be used for the study of Heart failure[1].

Product Specifications

CAS Number

[1245620-47-6]

UNSPSC

12352005

Target

Vasopressin Receptor

Related Pathways

GPCR/G Protein

Field of Research

Cardiovascular Disease

Smiles

O=C(N[C@H](C1=CC=CC(C(F)(F)F)=C1)COC(N)=O)CN2N=C(C3=CC=C(Cl)C=C3)N(C[C@H](O)C(F)(F)F)C2=O

Molecular Formula

C23H20ClF6N5O5

Molecular Weight

595.88

References & Citations

[1]Ulf Brüggemeier, et al. Substituted 2-acetamido-5-aryl-1,2,4-triazolones as vasopressin receptor inhibitors and their preparation and use in the treatment of cardiovascular diseases. WO2010105770 A1.|[2]Peter Kolkhof, et al. Preparation of triazole derivatives as V1a receptor antagonists for use in the treatment and prevention of renal diseases. WO2017191117 A1.